Literature DB >> 10410275

Juvenile arthritis--who gets it, where and when? A review of current data on incidence and prevalence.

B Andersson Gäre1.   

Abstract

Epidemiological studies of chronic arthritis in childhood can provide clues to genetic determinants of disease manifestations and environmental triggers. Available data are difficult to compare, however, because of the heterogeneity of the disease, differences in the classification criteria used for definition and inclusion, and differences in source populations and case ascertainment. Nevertheless, when the data are interpreted according to the methodologies used, geographical and ethnic differences can be found with regard to occurrence rates, age at onset, subgroup distribution and immunological markers. Seasonal variations have been detected in systemic disease. Variations in the incidence of childhood arthritis over time have also been observed, indicating environmental influences on disease frequency, while familial aggregations suggest the presence of genetic factors. These epidemiological data from a challenging puzzle which we hope will provide clues to future understanding of etiologies and cures, with the help of basic scientific research.

Entities:  

Mesh:

Year:  1999        PMID: 10410275

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  28 in total

Review 1.  Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence.

Authors:  Gerald Gartlehner; Richard A Hansen; Beth L Jonas; Patricia Thieda; Kathleen N Lohr
Journal:  Clin Rheumatol       Date:  2007-06-15       Impact factor: 2.980

2.  Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study.

Authors:  Norman Ilowite; Oscar Porras; Andreas Reiff; Sue Rudge; Marilynn Punaro; Alan Martin; Roger Allen; Terry Harville; Yu-Nien Sun; Terry Bevirt; Gary Aras; Brent Appleton
Journal:  Clin Rheumatol       Date:  2008-09-03       Impact factor: 2.980

Review 3.  Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?

Authors:  Heinrike Schmeling; Gerd Horneff; Susanne M Benseler; Marvin J Fritzler
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

Review 4.  [Uveitis in conjunction with rheumatological diseases in childhood].

Authors:  C Sengler; R Keitzer; U Pleyer
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

5.  Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009.

Authors:  Leslie R Harrold; Craig Salman; Stanford Shoor; Jeffrey R Curtis; Maryam M Asgari; Joel M Gelfand; Jashin J Wu; Lisa J Herrinton
Journal:  J Rheumatol       Date:  2013-04-15       Impact factor: 4.666

6.  Exposure to animals and risk of oligoarticular juvenile idiopathic arthritis: a multicenter case-control study.

Authors:  Katja Radon; Doris Windstetter; David Poluda; Renate Häfner; Silke Thomas; Hartmut Michels; Erika von Mutius
Journal:  BMC Musculoskelet Disord       Date:  2010-04-20       Impact factor: 2.362

7.  HLA B27 allele types in homogeneous groups of juvenile idiopathic arthritis patients in Latvia.

Authors:  Valda Stanevicha; Jelena Eglite; Dace Zavadska; Arturs Sochnevs; Arina Lazareva; Dinara Guseinova; Ruta Shantere; Dace Gardovska
Journal:  Pediatr Rheumatol Online J       Date:  2010-10-14       Impact factor: 3.054

8.  Abatacept in difficult-to-treat juvenile idiopathic arthritis.

Authors:  Jasmin B Kuemmerle-Deschner; Sm Benseler
Journal:  Biologics       Date:  2008-12

9.  The incidence of juvenile rheumatoid arthritis in Quebec: a population data-based study.

Authors:  Debbie Ehrmann Feldman; Sasha Bernatsky; Michelle Houde
Journal:  Pediatr Rheumatol Online J       Date:  2009-11-19       Impact factor: 3.054

Review 10.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.